Zetia, Ezetimibe

Bookmark

Add to MyYahoo RSS

Zetia, Ezetimibe News

News on Zetia, Ezetimibe (generic) continually updated from thousands of sources around the net.

Sunday Apr 13 | The Motley Fool

The Cost to Treat Cholesterol Plummets, But Will It Last?

Every year, Express Scripts crunches the previous year's data to uncover payer spending trends.

Comment?

Related Topix: Medicine, Cholesterol, Health, Lipitor, Atorvastatin (generic), Healthcare Law, Law

Thu Apr 03, 2014

P&T Community

Evolocumab Reduces LDL Cholesterol in Phase III Studies

In data from two phase III pivotal studies, treatment with the investigational cholesterol-lowering medication evolocumab resulted in statistically significant reductions in low-density lipoprotein cholesterol of 37% to 39% compared with ezetimibe in patients with high cholesterol who could not tolerate statins , and significant reductions of 55% ... (more)

Comment?

Related Topix: Medicine, Cholesterol, Health, Mathematics, Science

Tue Apr 01, 2014

Forbes.com

How Did A 30 Year Big Pharma Veteran Become An FDA Apologist?

I recently was contacted by a producer of the John Stossel Show, a weekly news show shown on the Fox Business Network.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration

Mon Mar 31, 2014

Science Daily

Evolocumab safely drops LDL cholesterol well below statin-only baseline, study suggests

The monoclonal antibody evolocumab produced highly significant reductions in low-density lipoprotein cholesterol, the "bad cholesterol," as an add-on to statins in all treatment groups, according to new data.

Comment?

Related Topix: Medicine, Cholesterol, Health, University of Iowa

P&T Community

Evolocumab Reduces LDL Cholesterol in Phase III Studies

In data from two phase III pivotal studies, treatment with the investigational cholesterol-lowering medication evolocumab resulted in statistically significant reductions in low-density lipoprotein cholesterol of 37% to 39% compared with ezetimibe in patients with high cholesterol who could not tolerate statins , and significant reductions of 55% ... (more)

Comment?

Related Topix: Medicine, Cholesterol, Health, Mathematics, Science

Canada.com

New drugs greatly lower cholesterol, may provide alternative to statins

A new class of experimental medicines can dramatically lower cholesterol, raising hopes of a fresh option for people who can't tolerate or don't get enough help from Lipitor and other statin drugs that have been used for this for decades.

Comment?

Related Topix: Medicine, Cholesterol, Health, Lipitor, Atorvastatin (generic), Cardiology

The Motley Fool

Today's Top Biotech Stories: Curis, Amgen, and Novartis

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

Comment?

Related Topix: Curis, Healthcare Law, Law, Medicine, Health, Breast Cancer

TheStreet.com

Saxena: Amgen Drug Cuts Cholesterol Levels In Pivotal Studies

Unlike statins, which are pills, the new PCSK9 inhibitors are injected through the skin.

Comment?

Related Topix: Medicine, Cholesterol, Health, Biotech, Regeneron Pharmaceuticals, Healthcare Industry, Healthcare Law, Law, Business News

Sun Mar 30, 2014

HON

New Drug Lowers Cholesterol Beyond What Statins Can Do, Study Finds

Two studies find that an experimental cholesterol-lowering drug is effective when combined with statins and beats another add-on drug when it comes to helping hard-to-treat patients.

Comment?

Related Topix: Medicine, Cholesterol, Health, UC Los Angeles, Lipitor, Atorvastatin (generic), Zocor, Simvastatin (generic), Valley Stream, NY

Sys-Con Media

Data From Phase 3 Pivotal Studies Show Amgen's Novel...

Data From Two Separate Phase 3 Studies of Evolocumab , a PCSK9 Inhibitor, Presented in Late-Breaking Clinical Trials Session at ACC.14 - Data Add to the Three Pivotal Studies Presented Yesterday /PRNewswire/ -- Amgen today announced new detailed data from two Phase 3 pivotal studies that showed treatment with its novel investigational ... (more)

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Mathematics, Science

Sat Mar 29, 2014

Washington Post

National roundup: Experimental drugs found to lower cholesterol

A new class of experimental medicines can dramatically lower cholesterol, raising hopes of a fresh option for people who can't tolerate or don't get enough help from statin drugs that have been used for decades.

Comment?

Related Topix: Salt Lake City, UT, US News, Liberal Political News

ABC News

Studies Find New Drugs Greatly Lower Cholesterol

A new class of experimental medicines can dramatically lower cholesterol, raising hopes of a fresh option for people who can't tolerate or don't get enough help from Lipitor and other statin drugs that have been used for this for decades.

Comment?

Related Topix: Medicine, Cholesterol, Health, Lipitor, Atorvastatin (generic), Cardiology

Wed Mar 26, 2014

Sys-Con Media

Sanofi and Regeneron To Present Alirocumab Clinical Data at the...

"We are presenting new data with our 150 mg four-week dosing regimen in individuals not receiving statins and long-term data in heterozygous familial hypercholesterolemia patients."

Comment?

Related Topix: Biotech, Medicine, Regeneron Pharmaceuticals, Healthcare Industry, The Data Company, Law, Cholesterol, Health, Pharmacology

•••
•••
•••
•••
•••
•••
•••
•••